Biopharmaceutical Contract Manufacturing to Reach Over $25 Billion by 2027. Contract manufacturing of live-attenuated Vaccines gaining popularity – Arizton

·4 min read
Arizton Advisory and Intelligence
Arizton Advisory and Intelligence

Vendors are strategically focused on developing and marketing single-use bioprocessing products to remain competitive and gain a foothold in the market. Product approvals and launches coupled with R&D activities help vendors to expand their footprint, drive market growth, and maintain their position in the US gene therapy market.

Chicago, Aug. 09, 2022 (GLOBE NEWSWIRE) -- According to latest research report, biopharmaceutical contract manufacturing market to grow at a CAGR of over 14% during 2022-2027. Live-attenuated vaccines are among the most widely used vaccination technologies. These vaccines have complex manufacturing requirements and continue to tighten pharma and biotech R&D budgets. Therefore, companies are trying to meet healthcare needs through low costing and highly effective manufacturing processes, thereby facilitating the growth of the vaccine contract manufacturing sector.

Contract manufacturing services serve as a strategy for various companies ranging from big pharma players to small specialty entities. Major factors driving the demand for contract manufacturers include continuous cost-cutting efforts, decreased time to market, growing specialty firms that lack in-house manufacturing facilities, and an increase in outsourcing activities. In recent years, pricing pressures have been driving contract manufacturers to increase their operations in the market.

Biopharmaceutical Contract Manufacturing Market Report Scope

Report Attributes

Details

MARKET SIZE (2027)

Over $25 Billion

MARKET SIZE (2021)

$11.30 Billion

CAGR (2022-2027)

Over 14%

BASE YEAR

2021

FORECAST YEAR

2022-2027

MARKET SEGMENTS

Product, Biologics, Expression System, Scale of Operations, Company Size, and Geography

GEOGRAPHIC ANALYSIS

North America, Europe, APAC, Latin America, and Middle East & Africa

Click Here to Download the Free Sample Report

Impact of Robust Biopharmaceuticals Pipeline

Pharmaceutical companies' approach is to provide drugs that significantly improve the quality of life of patients suffering from autoimmune disorders and chronic inflammations. Scientists in R&D programs are working to accelerate the delivery of new therapies. Cell and & Gene Therapy is emerging as one of the most dynamic fields in medicine with an increased number of ongoing R&D activities. Many vendors and research organizations are engaged in the R&D of Cell & Gene Therapy. The key vendors are increasingly conducting clinical trials to gain regulatory approval in the US with largely untapped potential.

Key Insights

  • The emergence of various infectious diseases in developing and low- and middle-income countries are raising the usage of biologics and demanding the introduction of newer biologics, which creates opportunities for market growth.

  • The spread of infectious diseases across regions owing to increasing populations and implementation of vaccination programs have raised the clinical demand for vaccines, which is driving the growth of the biopharmaceutical contract manufacturing market.

  • The large companies contributed to substantial revenues, and small & mid-sized companies are expected to witness an absolute growth of 126.43%during the forecast period.

  • The research (clinical & preclinical) segment contributed to substantial revenues and is expected to witness an absolute growth of 128.47% during 2022-2028.

  • North America dominated the global market, followed by Europe, APAC, Latin America, and Middle East & Africa. APAC is anticipated to grow with the highest CAGR because of the high prevalence of disease, the demand for biopharmaceutical production, and the presence of many biopharmaceutical contract manufacturers.

Vendors Insights

The emergence of several start-ups and emerging players intensified the competition among vendors. Major vendors offering biopharmaceutical contract manufacturing services are present in the region of North America, including small, mid-sized, or even large companies. Europe and APAC contain a few larger players and several small and mid-sized vendors. Emerging economies, such as China, India, Brazil, and Mexico, are likely to offer significant growth opportunities for players in the biopharmaceutical contract manufacturing market. With increasing competition and the emergence of several companies, major vendors are getting more active and are focusing on more diverse contract manufacturing services as required by end-users.

Market Segmentation

Product Type

  • Finished Dosage Form (FDF)

  • Active Pharmaceutical Ingredients (APIs)

Biologics

  • Monoclonal Antibodies (mAbs)

  • Vaccines

  • Others

Expression System

  • Mammalian

  • Non-Mammalian

Scale of Operations

  • Commercial

  • Research (Clinical & Preclinical)

Company Size

  • Large & Very Large Companies

  • Small & Mid-Sized Companies

Geography

  • Europe

    • Germany

    • UK

    • France

    • Switzerland

    • Italy

    • Spain

  • APAC

    • China

    • Japan

    • South Korea

    • Australia

    • India

  • North America

    • US

    • Canada

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • South Africa

    • Turkey

Key Vendors

  • Boehringer Ingelheim

  • Lonza

  • Samsung Biologics

Key Companies

  • AbbVie

  • Catalent

  • Emergent BioSolutions

  • FUJIFILM

  • Merck KGaA

  • Pfizer

  • Serum Institute of India

  • WuXi Biologics

Other Prominent Vendors

  • AGC Biologics

  • Ajinomoto

  • Albany Molecular Research (AMRI)

  • Asymchem

  • Biocon

  • Cobra Biologics

  • Charles River Laboratories

  • Goodwin Biotechnology

  • KBI Biopharma

  • Sanofi

  • Bavarian Nordic

  • Wacker Biotech B.V

  • Jubilant HollisterStier

  • National Resilience

  • Novasep

  • Kemwell Biopharma

  • Midas Pharma

  • Alcami

  • Cambrex

  • Pharmaceutics International

  • Singota Solutions

  • Thermo Fisher Scientific

  • Binexc

  • Canton Biologics

  • ChemPartner

  • Cytovance Biologics

Explore  healthcare lifesciences profile to know more about the industry.

Click Here to Download the Free Sample Report

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Click Here to Contact Us

Call: +1-312-235-2040  
+1 302 469 0707

CONTACT: Arizton Advisory and Intelligence Call: +1-312-235-2040  +1 302 469 0707